Physician profile
Todd A Shettle
NPI 1194725663
$1,034.28
in general payments reported to CMS, 2019-2025
12 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $147 · 2021: $37.12 · 2022: $59.43 · 2023: $180 · 2024: $257 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532 · Entertainment: $21.04 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.62 |
| Entertainment | $21.04 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $239.00 | 2022-2025 | Miebo |
| Maculogix, INC. | $129.36 | 2020 | |
| New World Medical,INC. | $113.67 | 2023 | |
| Coopervision INC. | $109.42 | 2019-2020 | |
| Astellas Pharma US INC | $105.76 | 2024 | Izervay |
| Abb Con-Cise Optical Group LLC | $97.00 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.96 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $53.70 | 2025 | |
| Genzyme Corporation | $50.00 | 2024 | |
| Optos, INC. | $38.92 | 2021-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $19.25 | 2019 | |
| Sight Sciences, INC. | $19.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Shettle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.